ArticleJCEM case reports2026
Graves disease complicated by agranulocytosis and thrombocytopenia in a 12-year-old girl.
Article in JCEM case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Graves disease is the most common cause of hyperthyroidism in children. Although neutropenia and thrombocytopenia have been reported in adults with untreated Graves disease, these complications are rare in children. Here, we report a pediatric case of Graves disease complicated by agranulocytosis and thrombocytopenia at diagnosis. A 12-year-old girl presented with increased appetite, irritability, fever, and petechiae. Laboratory examination revealed thyrotoxicosis, and this was associated with agranulocytosis and thrombocytopenia. There was no history of antithyroid drug use. The diagnosis of Graves disease was established based on positive thyroid-stimulating hormone receptor antibodies and thyroid scintigraphy findings. After initiation of a β-blocker and potassium iodide, neutrophil and platelet counts gradually improved in association with the resolution of thyrotoxicosis, which allowed the subsequent introduction of methimazole. The β-blocker and potassium iodide were sequentially discontinued. Blood cell counts remained within the normal range thereafter, and thyroid function has remained well controlled with methimazole monotherapy. This case suggests that thyrotoxicosis itself is associated with cytopenia and provides valuable insight for clinicians when selecting a therapeutic strategy for Graves disease complicated by cytopenia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.